Unknown

Dataset Information

0

Structural basis of sialidase in complex with geranylated flavonoids as potent natural inhibitors.


ABSTRACT: Sialidase catalyzes the removal of a terminal sialic acid from glycoconjugates and plays a pivotal role in nutrition, cellular interactions and pathogenesis mediating various infectious diseases including cholera, influenza and sepsis. An array of antiviral sialidase agents have been developed and are commercially available, such as zanamivir and oseltamivir for treating influenza. However, the development of bacterial sialidase inhibitors has been much less successful. Here, natural polyphenolic geranylated flavonoids which show significant inhibitory effects against Cp-NanI, a sialidase from Clostridium perfringens, are reported. This bacterium causes various gastrointestinal diseases. The crystal structure of the Cp-NanI catalytic domain in complex with the best inhibitor, diplacone, is also presented. This structure explains how diplacone generates a stable enzyme-inhibitor complex. These results provide a structural framework for understanding the interaction between sialidase and natural flavonoids, which are promising scaffolds on which to discover new anti-sialidase agents.

SUBMITTER: Lee Y 

PROVIDER: S-EPMC4014123 | biostudies-literature | 2014 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural basis of sialidase in complex with geranylated flavonoids as potent natural inhibitors.

Lee Youngjin Y   Ryu Young Bae YB   Youn Hyung-Seop HS   Cho Jung Keun JK   Kim Young Min YM   Park Ji-Young JY   Lee Woo Song WS   Park Ki Hun KH   Eom Soo Hyun SH  

Acta crystallographica. Section D, Biological crystallography 20140430 Pt 5


Sialidase catalyzes the removal of a terminal sialic acid from glycoconjugates and plays a pivotal role in nutrition, cellular interactions and pathogenesis mediating various infectious diseases including cholera, influenza and sepsis. An array of antiviral sialidase agents have been developed and are commercially available, such as zanamivir and oseltamivir for treating influenza. However, the development of bacterial sialidase inhibitors has been much less successful. Here, natural polyphenoli  ...[more]

Similar Datasets

| S-EPMC7088933 | biostudies-literature
| S-EPMC5983823 | biostudies-literature
| S-EPMC6374116 | biostudies-literature
| S-EPMC7162010 | biostudies-literature
| S-EPMC6493668 | biostudies-literature
| S-EPMC4822154 | biostudies-literature
| S-EPMC4788501 | biostudies-literature
| S-EPMC8781960 | biostudies-literature
| S-EPMC7126831 | biostudies-literature
| S-EPMC6010085 | biostudies-literature